D.E. Shaw & Co
SBC

D.E. Shaw & Co’s SBC Medical Group SBC Stock Holding History

D.E. Shaw & Co’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-172,500
Closed -$1.8M – 4634
2023
Q1 		$1.8M Hold
172,500
– – ﹤0.01% 2764
2022
Q4 		$1.77M Buy
+172,500
New +$1.75M ﹤0.01% 3032

Other funds holding SBC

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return

D.E. Shaw & Co's SBC Position: Q2 2023 in Review

D.E. Shaw & Co sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 172,500 shares — an estimated $1.8M sold.

D.E. Shaw & Co first reported a position in SBC in Q4 2022 and held it in 2 quarters. The position peaked at $1.8M in Q1 2023. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

  • D.E. Shaw & Co reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 172,500 SBC Medical Group shares in Q2 2023, an estimated $1.8M.
  • D.E. Shaw & Co first reported a position in SBC Medical Group in Q4 2022 and held it in 2 quarters.
  • D.E. Shaw & Co's SBC Medical Group position peaked at $1.8M in Q1 2023.
  • 13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.